About Larry Dillaha
Form D filings for Melt Pharmaceuticals from 2019 to 2024 list Larry Dillaha as executive officer and director.
Larry Dillaha first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Larry Dillaha in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Larry Dillaha works with at each company, as listed on that company's latest Form D.
Melt Pharmaceuticals, Inc. · Form D/A, Apr 8, 2024
BO
Brad Osborne
Chief Financial Officer